Trend in Deaths Among Men

Men have experienced a fluctuating yet overall increasing trend in deaths due to myelodysplastic syndrome in Spain, with the lowest recorded number being 438 deaths in 2008 and the highest 707 deaths in 2017. The numbers reveal a significant increase of 269 deaths over this period, indicating a growing impact of the disease on the male population.

Trend in Deaths Among Women

Women have shown a more stable pattern in mortality rates from myelodysplastic syndrome, with a gradual increase from 294 deaths in 2006 to 517 deaths in 2015, followed by a slight fluctuation. The peak for women was observed in 2015 and 2016, each with over 500 deaths, highlighting a critical period for female health concern related to this syndrome.

Gender Disparity in Mortality

Throughout the years 2005-2022, men consistently reported higher numbers of deaths from myelodysplastic syndrome than women, with a notable difference reaching up to 209 more deaths in men than women in 2017. This disparity underscores a significant gender-based difference in the impact of the disease.

Yearly Variability and Peak Incidents

The data exhibits noticeable yearly fluctuations in deaths among both genders, with 2017 marking the year of maximum deaths for men (707) and 2015 and 2016 for women (with over 500 deaths each). These variations suggest the influence of external factors or possibly changes in diagnosis or treatment efficacy over time.

Long-term Growth in Mortality Rates

Over the 18-year span from 2005 to 2022, there has been a general upward trend in mortality from myelodysplastic syndrome for both men and women, indicating an increasing burden of the disease in Spain. The cumulative increase highlights the need for enhanced medical and policy attention towards this condition.

Comparison with the Earliest and Latest Recorded Data

Comparing the earliest (2005) and the latest data points (2022), there has been an increase of 42.11% in male deaths and 34.87% in female deaths. This comparison showcases a significant rise in fatalities over nearly two decades, emphasizing the growing challenge myelodysplastic syndrome poses to public health.

Overall Mortality Increase

The total number of deaths from myelodysplastic syndrome has risen from 810 in 2005 to 1,126 in 2022, marking an overall increase of 39%. This comprehensive growth reflects an escalating health concern that requires ongoing research and improved treatment strategies.